Washington, DC (January 12, 2016) – The National Health Council (NHC) publicly thanked the Members of the Senate Committee on Health, Education, Labor, and Pensions for unanimously approving the nomination of Dr. Robert Califf to be the next Commissioner of the Food and Drug Administration (FDA). The following statement is from NHC’s Chief Executive Officer, Marc Boutin:
“To advance the delivery of quality care in this country, the FDA must ensure that the voices of people with chronic diseases and disabilities are incorporated into the research, development, and regulation of medical products. Dr. Califf has proven through his varied career the ability to engage patients and bring multiple points of view to help tackle complex issues. The patient advocacy community urges the full Senate to confirm Dr. Califf as FDA Commissioner.
“We need an FDA that is open to new possibilities, that has an investigative spirit to consider different pathways, and is committed to seeking the valued input of the end user – the patient.”
Founded in 1920, the National Health Council (NHC) is the only organization that brings together all segments of the health community to provide a united and effective voice for the more than 133 million people living with chronic diseases and disabilities and their family caregivers. Made up of more than 100 national health-related organizations and businesses, its core membership includes the nation’s leading patient advocacy organizations, which control its governance. Other members include professional and membership associations, nonprofit organizations with an interest in health, and major health insurance, pharmaceutical, medical device, and biotechnology companies.